Literature DB >> 11439366

Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer.

S Ogata 1, G Tamura, Y Endoh, K Sakata, K Ohmura, T Motoyama.   

Abstract

Multiple gastric cancers may develop through the same genetic background: the mutator pathway due to defects in DNA mismatch repair genes, or the suppressor pathway due to defects in tumour suppressor genes. To clarify the critical genetic events in the early stages of multiple gastric cancer development, 29 early and four advanced gastric cancers were examined from 12 patients. Microsatellite alterations were studied involving microsatellite instability (MSI) and loss of heterozygosity (LOH) at tumour suppressor loci, representative of the mutator pathway and the suppressor pathway, respectively, as well as mutations of target genes (TGF-beta RII, BAX, hMSH3, and E2F-4). MSI was determined in ten cancers (10/33; 30.3%) from seven patients (7/12; 58.3%). LOH was detected in six cancers (6/33; 18.2%) from five patients (5/12; 41.7%), most frequently at TP53, in four cancers (4/33; 12.1%) from four patients (4/12; 33.3%). In cases with multiple gastric cancers in the same stomach, the MSI status was generally the same, but in two patients (2/12; 16.8%) a tumour with MSI-H and another with LOH were found to co-exist in the same stomach. As for mutations of the target genes, it was found that E2F-4 was mutated in six cancers (6/33; 18.2%) from four patients (4/12; 33.3%). Furthermore, identical E2F-4 mutations were detected in four of the six intestinal metaplastic mucosae adjacent to each cancer carrying an E2F-4 mutation. No mutations were detected in the other target genes. In conclusion, the present results indicate that the majority of multiple gastric cancers develop from the same genetic background, with the mutator pathway playing a more important role than the suppressor pathway. Mutations of E2F-4 are early events in multiple gastric cancer development, occurring even in the intestinal metaplastic mucosa, with mutations of other target genes to follow during cancer progression. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11439366     DOI: 10.1002/path.895

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  Long-term outcome and surveillance policy after endoscopic therapy for early gastric cancer.

Authors:  Kentaro Sugano
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

2.  Differences in genomic instability between intestinal- and diffuse-type gastric cancer.

Authors:  Matti Vauhkonen; Hanna Vauhkonen; Antti Sajantila; Pentti Sipponen
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability.

Authors:  Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang; Jian-Ming Yang; Hai-Feng Liu; Gui-Yong Peng; Tian-Li Xiao; Yuan-Hui Luo
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.

Authors:  Naoyuki Homma; Gen Tamura; Teiichiro Honda; Zhe Jin; Kiyonari Ohmura; Sumio Kawata; Teiichi Motoyama
Journal:  Virchows Arch       Date:  2004-12-10       Impact factor: 4.064

Review 5.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 6.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

7.  Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.

Authors:  Masakazu Yashiro; Kosei Hirakawa; C Richard Boland
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

Review 8.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 9.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 10.  Implication of microsatellite instability in human gastric cancers.

Authors:  Upasana Shokal; Prakash C Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.